GLG News Analyses of the following article:
Sun Pharma gets US nod for two generic drugs
Published at: economictimes.indiatimes.com
-
SUN PHARMA GETS US NOD FOR 2 GENERIC Drugs
August 18, 2009
It will definetly boost the share price if SUN Pharma in India and it help to increse the share of sales in US marketing
-
2 generic drugs - Imitrex and Eloxatin
August 16, 2009
I do not have a problem with a generic-like Imitrex. I do for Eloxatin. Generics can be up to 20% off, so for migraine med, that is more acceptable than a cancer treatment.
- Subscribe to Updates
-
Work for one of the world's leading organizations? Get started now.
Get Intelligently Connected
with the world's leading experts
GLG's 850+ Clients Include:
- More than 70% of the world's leading
- mutual funds
- 15 of the leading 20
- global banks
- 9 of the leading 10
- global private equity firms
- 5 of the leading 10
- AmLaw firms
- Fortune 500® Companies
- in nearly every industry sector, including pharmaceuticals, insurance, chemicals, energy and computer software
Gerson Lehrman Group, Inc. connects communities with knowledge through two distinct, yet complementary offerings: GLG Research and G+.